Skip to the page

Data / Medical devices / South Korea / SCL Science Inc.

SCL Science Inc.: FDA-registered device maker in Seoul, South Korea, 1 510(k) clearance

SCL Science Inc. is registered with the FDA (registration 3014136088) in Seoul, South Korea. It lists 1 device type. The FDA files 1 510(k) clearance under its listings, the newest dated November 29, 2016. Registered through 2026. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3014136088
Address
#1206-1210, ACE hightechcity 2 25, Seonyu-ro 13-gil, Yeongdeungpo-gu, Seoul, South Korea, 07282
Owner or operator
InnoTherapy Inc. (10053735)
Roles
Manufacturer
First device listed
January 5, 2017
Registered through
2026
Brand names listed
InnoSEAL Hemostatic Pad

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
November 29, 2016K161013InnoSEAL Hemostatic PadQSYSubstantially EquivalentInnotherapy, Inc.accessdata.fda.gov

Compare with other makers

Updated November 29, 2016. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.